Medidata Institute

Conference Abstracts and Posters

Conference Abstracts and Posters

Pooled Clinical Trial Data Analyses Comparing the Biology of HER2-low vs HER2-0 Breast Cancer in Patients with Metastatic Breast Cancer Following Treatment with Standard Single Agent Chemotherapy

Phosphorus disruption is associated with the incidence and severity of neurotoxicity symptoms in CD19-targeted CAR T-cell therapy: a pooled clinical trial analysis

Machine Learning-Based Decision Tree for Identifying and Grading Severity of ICANS Based on Neurological Adverse Events in Patients Treated with CD19 CAR T-Cell

Significant Cytokine Release Syndrome Risk Model With T-Cell Engaging Therapies

Research Hub Framework: Optimizing T-Cell Redirecting Therapies Through Multi-Sector Collaborations and Data

PMSA May 2023 Poster Tree Based Marketing Mix Models

EHA CAR T-cell Meeting: Co-occurrence patterns of CRS and ICANS in patients undergoing autologous CD19-targeted CAR T-cell treatments

Brain Metastases in Patients with KRAS Mutant Advanced NSCLC Receiving Docetaxel: Pooled Clinical Trial Data Analysis

NEALS: CA3 levels in plasma associate strongly with site of onset in ALS

ASCO: Assessment of Vitamin D deficiency and COVID-19 diagnosis in patients with breast or prostate cancer using Electronic Medical Records

ASCO: Oncology trial enrollment trends following the first wave of the COVID-19 pandemic.

ASCO: Assessment of Vitamin D deficiency and COVID-19 diagnosis in patients with breast or prostate cancer using Electronic Medical Records

ASCO: Oncology Trial Enrollment Trends Following the First Wave of the COVID-19 Pandemic

ASH: Racial Differences in Multiple Myeloma Survival Using Clinical Trial and Real-World EMR Data

ASH: Racial Differences in Multiple Myeloma Survival Using Clinical Trial and Real-World EMR Data

ISPOR EU: Treatment Patterns of Antihypertensive Medications Among Alzheimer’s Disease Patients in United States and Europe

ISPOR EU: Healthcare Resource Utilization Among Alzheimer’s Disease Patients Using Antihypertensive Medication in United States and France

ISPOR EU: Identifying the Baseline Characteristics of Heart Failure Patients That Receive and Do Not Receive the Seasonal Influenza Vaccine

ISPOR EU: Clinical and Demographic Factors Associated with Prescribing Disease Modifying Agents in Multiple Sclerosis Patients

ESMO: Does Race Impact Outcomes in Triple Negative Breast Cancer?

AACR: COVID-19 Pandemic Slows Launch of Oncology Clinical Trials

AACR: COVID-19 Pandemic Slows Launch of Oncology Clinical Trials

ASCO: Exploring the validity of a SCA in difficult-to-study indications: A case study in relapsed/refractory multiple myeloma

ASCO: Evaluating progression-free survival in black and white women with breast cancer in pooled clinical trials from a synthetic control database and real-world EMR

ASCO: Assessing the relationship in relapsed-refractory multiple myeloma between pooled clinical trial subjects and a real-world EMR data source

ASCO: Error-free, automated data integration of exosome cargo protein data with clinical data in an ongoing, multi-omic translational study

2020 Presentation Abstract

JSM: Data Standardization to Facilitate Comparison of Real World Data and Clinical Trial Data

2020 Poster Abstract

JSM: Bayesian Synthetic Control Approaches in Pediatric Drug Development in ALL

ASCO: Results of a Randomized Control Arm are Replicated by a Synthetic Control Arm in NSCLC

ISPOR EU: Prescription Pattern and Physician Propensity for CHF Treatments in US and EU

ISPOR EU: Health Resource Utilization in Advanced Ovarian and Endometrial Cancer in a United States Insurance Claims Database

ISPOR EU: Using Clinical Data Standards to Facilitate Comparisons of AML Treatment Patterns and Outcomes in Real-World Clinical Care and Pooled Clinical Trial Populations

ISPOR EU: Patterns and Prediction for Cognitive Decline in Alzheimer’s Patients Assessed by the Mini-Mental Status Exam in an Ambulatory EMR

ISPOR EU: Evaluation of Missing Data Imputation Strategies in Clinical Trial and EMR Data Using Standardized Data Models

ISPOR EU: 3C-HF Prognostic Score to Predict Worsening Cardiac Function Among Congestive Heart Failure Patients in United States and Europe

ISPOR EU: Scalable Prediction of Cancer Patient Clinical Events in Real-World Clinical Settings

ISPOR US: Persistence to oral and injectable multiple sclerosis disease-modifying therapies

ISPOR US: A Systematic Approach For Synthetic Replication Of Clinical Trial Cohorts Using Retrospective Real-world And Clinical Trial Data

ISPOR US: A Systematic Approach For Quantifying Heterogeneity Within Clinical Trial Populations

ISPOR US: Predicting Chemotherapy-associated Thrombocytopenia In Real World Clinical Settings

ISPOR US: Real World Replication Of Clinical Trial Findings In Alzheimer’s Disease

ASH: Quantitative Changes in Serum Proteins are Early Indicators of Response to Anti-IL6 Therapy in Idiopathic Multicentric Castleman Disease

JSM: Bayesian Synthetic Control Approaches in Pediatric Drug Development: A Case Study in ALL

PSI Best Poster Award: Using Synthetic Control Databases to Accelerate Indication-Specific Safety and Efficacy Evidence

2019 Poster Abstract

DIA: Using Synthetic Control Databases to Accelerate Indication-Specific Safety and Efficacy Evidence

DIA: Using Synthetic Control Databases to Accelerate Indication-Specific Safety and Efficacy Evidence

ASH: Serum Proteomics Reveals Distinct Subtypes Associated with Treatment Response in Idiopathic Multicentric Castleman Disease

ASCO: Creating a synthetic control arm from previous clinical trials: Application to establishing early end points as indicators of overall survival in AML

SOCRA: The use of Electronic Informed Consent (eConsent) in a Blood Collection Study